ENG

Julia Laboratory as Research-Oriented Bio-Venture Company

Julia Laboratory is using biochemical tools, including functional proteomics, epigenetics, metabolomics, and bioinformatics tools to synthesize new drugs to treat age-related macular degeneration and Alzheimer’s diseases.
Julia Lab has accumulated the largest amount of data on genome, proteome, and metabolome of AMD and Alzheimer’s diseases for the last twenty five years.
Julia Laboratory is a science-based, research-oriented company aiming to the world best eye research institute, including Schepense Eye Institute, and competes with the multinational pharmaceutical companies, including Merck, Pfizer, Genentech, Norvatis, Allegan, Regeneron, and Bayer.

Julia Laboratory

New drug development through the retina specialist, organic chemists, clinicians, pharmacists, in addition to accumulated research data

Continuous development

Core Competencies

Julia Lab’s Omics DBs

Protein Map, Metabolomics Libraries

Julia Lab’s Drug Design Platform

Julia Lab’s Drug DBs

Julia Lab’s R&D Capability

We analyze the disease mechanism at the molecular level to develop to protein target, biomarkers, and drug structures.

Julia Laboratory is a venture company that designs and manufactures new drugs for macular degeneration and dementia using proteomics and metabolomics tools. We will continue to develop new drugs based on accumulated data.

Related Papers

Year of Establishment

Expected Listing